1. Home
  2. LPL vs GPCR Comparison

LPL vs GPCR Comparison

Compare LPL & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LG Display Co Ltd AMERICAN DEPOSITORY SHARES

LPL

LG Display Co Ltd AMERICAN DEPOSITORY SHARES

N/A

Current Price

$3.32

Market Cap

3.3B

Sector

Technology

ML Signal

N/A

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

N/A

Current Price

$38.79

Market Cap

3.8B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
LPL
GPCR
Founded
1985
2016
Country
South Korea
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.8B
IPO Year
2004
2023

Fundamental Metrics

Financial Performance
Metric
LPL
GPCR
Price
$3.32
$38.79
Analyst Decision
Hold
Strong Buy
Analyst Count
1
12
Target Price
N/A
$103.17
AVG Volume (30 Days)
2.2M
755.9K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.35
N/A
Revenue Next Year
$2.94
N/A
P/E Ratio
$25.64
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.76
$20.04
52 Week High
$5.83
$94.90

Technical Indicators

Market Signals
Indicator
LPL
GPCR
Relative Strength Index (RSI) 39.24 27.86
Support Level $2.76 $36.11
Resistance Level $3.43 $41.50
Average True Range (ATR) 0.10 2.45
MACD -0.01 -1.11
Stochastic Oscillator 5.26 2.07

Price Performance

Historical Comparison
LPL
GPCR

About LPL LG Display Co Ltd AMERICAN DEPOSITORY SHARES

LG Display Co Ltd manufacture TFT-LCD and OLED technology-based display panels in a broad range of sizes and specifications mainly for use in IT products (comprising notebook computers, desktop monitors and tablet computers), televisions, mobile devices, including smartphones, as well as auto products, and it are one of the world's suppliers of large-sized OLED television panels. It also manufacture display panels for industrial and other applications, including entertainment systems and medical diagnostic equipment.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: